TARGET 2.0 Study: Safety and Performance of the Cardiovalve TR Replacement System

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT07334691

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Cardiovalve Ltd. (from the registry)
Registry
  • NCT NCT07334691
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07334691. Allocation not applicable; no masking; primary purpose treatment. Start 2026-01-20 (actual); primary completion 2028-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TARGET 2.0 Study: Safety and Performance of the Cardiovalve TR Replacement System
Condition
Tricuspid Regurgitation
Intervention (Device)
Cardiovalve TR valve replacement System
Lead sponsor
Cardiovalve Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07334691
Content hash
3cef1244368115c2dacdd6227415a0f5506944b35d361cf1f060248981249d38